MetLife Board Approves $3 Billion Buyback Authorization
By Denny Jacob
MetLife on Wednesday said its board approved a $3 billion authorization for the company to repurchase its common stock.
The insurer said the new authorization is incremental to the $202 million remaining under its prior authorization from May 2022.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
May 03, 2023 16:42 ET (20:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Will Earnings From These 10 AI Stocks Live Up to the Hype?
-
What’s Happening In the Markets This Week
-
What the Next Bitcoin Halving Means for ETF Investors
-
Going Into Earnings, Is Microsoft a Buy, a Sell, or Fairly Valued?
-
Big Banks: High Interest Rates and Sticky Inflation Haven’t Dented Consumer Spending
-
Is the World Deglobalizing?
-
How to Position Your Investment Portfolio Before the 2024 Election
-
Q2 Update: 2024 Outlook for the Stock Market and Economy
-
Regions Financial Earnings: Mixed Quarter, 2024 Outlook Mostly Reiterated
-
Going Into Earnings, Is Amazon Stock a Buy, a Sell, or Fairly Valued?
-
Fifth Third Earnings: Mostly Solid Start to 2024
-
Israel’s Response to Iran’s Strike Confirms Minimal Escalation View; Oil Markets Remain Oversupplied
-
Procter & Gamble Earnings: Muted Sales Growth Doesn’t Reflect a Stained Brand Mix
-
TSMC Earnings: Shares Cheap as Cautious Capital Spending and Industry Outlook Dent Sentiment
-
Netflix Earnings: Incredible Quarter, but Investors Fear Slowdown
-
KeyCorp Earnings: 2024 Net Interest Income Outlook Unchanged; Fees Strong and Expenses Stable